Repligen ( (RGEN) ) has released a notification of late filing.
Repligen Corporation has announced a delay in filing its Form 10-K (Yearly Report) for the fiscal year ending December 31, 2024. The delay is primarily due to the additional time required to complete year-end reporting procedures and the audit of financial statements by independent auditors. The company expects to file the report within the extension period allowed under Rule 12b-25. Repligen does not anticipate any changes in financial results from those previously disclosed in their February 2025 earnings release. The company remains committed to compliance and transparency, as evidenced by the signature of CFO Jason K. Garland on the notification.
More about Repligen
YTD Price Performance: 11.33%
Average Trading Volume: 567,358
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $8.92B
For a thorough assessment of RGEN stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com